C19ORF70 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.509800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.263800E-01
Normal-vs-Stage2
4.299000E-01
Normal-vs-Stage3
5.912600E-01
Normal-vs-Stage4
1.979840E-01
Stage1-vs-Stage2
4.572600E-01
Stage1-vs-Stage3
6.215800E-01
Stage1-vs-Stage4
6.509600E-01
Stage2-vs-Stage3
9.389600E-01
Stage2-vs-Stage4
9.017000E-01
Stage3-vs-Stage4
8.830400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.331000E-01
Normal-vs-AfricanAmerican
5.003800E-01
Normal-vs-Asian
3.005000E-01
Caucasian-vs-AfricanAmerican
4.266000E-01
Caucasian-vs-Asian
2.267800E-01
AfricanAmerican-vs-Asian
1.155790E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.738600E-01
Normal-vs-Female
3.106800E-01
Male-vs-Female
4.018400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.265800E-01
Normal-vs-Age(41-60Yrs)
4.360400E-01
Normal-vs-Age(61-80Yrs)
3.713400E-01
Normal-vs-Age(81-100Yrs)
2.925500E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.337200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.749400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.928200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
7.915800E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.488000E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.192000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.436200E-01
Normal-vs-Daily Drinker
3.115400E-01
Normal-vs-Weekly Drinker
2.825800E-01
Normal-vs-Occasional Drinker
2.343200E-01
Normal-vs-Social Drinker
4.881000E-01
Non Drinker-vs-Daily Drinker
1.552790E-01
Non Drinker-vs-Weekly Drinker
1.347790E-01
Non Drinker-vs-Occasional Drinker
4.759800E-01
Non Drinker-vs-Social Drinker
9.795400E-01
Daily Drinker-vs-Weekly Drinker
6.094800E-01
Daily Drinker-vs-Occasional Drinker
3.624000E-01
Daily Drinker-vs-Social Drinker
2.486400E-01
Weekly Drinker-vs-Occasional Drinker
2.439600E-01
Weekly Drinker-vs-Social Drinker
1.571570E-01
Occasional Drinker-vs-Social Drinker
5.712200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.334600E-01
Normal-vs-Grade 2
8.845600E-02
Normal-vs-Grade 3
2.094600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.288000E-01
Grade 1-vs-Grade 3
1.960450E-01
Grade 1-vs-Grade 4
3.334600E-01
Grade 2-vs-Grade 3
3.743400E-01
Grade 2-vs-Grade 4
8.845600E-02
Grade 3-vs-Grade 4
2.094600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.701800E-01
Normal-vs-NonDiabetic
2.690400E-01
Diabetic-vs-NonDiabetic
2.018200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
9.226100E-02
Normal-vs-NoPancreatitis
3.136200E-01
Pancreatitis-vs-NoPancreatitis
4.084200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.561210E-01
Normal-vs-N1
4.566200E-01
N0-vs-N1
1.267180E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.842400E-01
Normal-vs-TP53-NonMutant
6.832600E-01
TP53-Mutant-vs-TP53-NonMutant
6.119800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
